Cargando…
Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
BACKGROUND: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomogr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224246/ https://www.ncbi.nlm.nih.gov/pubmed/21774838 http://dx.doi.org/10.1186/1471-2474-12-166 |
_version_ | 1782217359849684992 |
---|---|
author | Yokouchi, Masahiro Terahara, Mikio Nagano, Satoshi Arishima, Yoshiya Zemmyo, Michihisa Yoshioka, Takako Tanimoto, Akihide Komiya, Setsuro |
author_facet | Yokouchi, Masahiro Terahara, Mikio Nagano, Satoshi Arishima, Yoshiya Zemmyo, Michihisa Yoshioka, Takako Tanimoto, Akihide Komiya, Setsuro |
author_sort | Yokouchi, Masahiro |
collection | PubMed |
description | BACKGROUND: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is a tool for diagnostic imaging that has recently spread rapidly in clinical use. At present, the roles played by FDG-PET/CT in determination of margins for surgical resection of sarcoma are unclear. The present study was undertaken to explore the roles of FDG-PET/CT in determination of surgical margins for soft tissue sarcoma and to examine whether PET can serve as a standard means for setting the margins of surgical resection during reduced surgery. METHODS: The study involved 7 patients with sarcoma who underwent surgery in our department and in whom evaluation with FDG-PET/CT was possible. Sarcoma was histologically rated as MFH in 6 cases and leiomyosarcoma in 1 case. In all cases, sarcoma was superficial (T1a or T2a). The tumor border was defined by contrast-enhanced MRI, and SUVs were measured at intervals of 1 cm over a 5-cm long area from the tumor border. Mapping of viable tumor cells was carried out on whole-mount sections of resected tissue, and SUVs were compared with histopathological findings. RESULTS: Preoperative maximum SUVs (SUV-max) of the tumor averaged 11.7 (range: 3.8-22.1). Mean SUV-max was 2.2 (range: 0.3-3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2 cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at 4 cm, and 0.64 (0.45-0.82) at 5 cm. When resected tissue was mapped, tumor cells were absent in the areas where SUV-max was below 1.0. CONCLUSIONS: Our findings suggest that a safe surgical margin free of viable tumor cells can be ensured if the SUV cut-off level is set at 1.0. FDG-PET/CT is promising as a diagnostic imaging technique for setting of safe minimal margins for surgical resection of soft tissue sarcoma. |
format | Online Article Text |
id | pubmed-3224246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32242462011-11-27 Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma Yokouchi, Masahiro Terahara, Mikio Nagano, Satoshi Arishima, Yoshiya Zemmyo, Michihisa Yoshioka, Takako Tanimoto, Akihide Komiya, Setsuro BMC Musculoskelet Disord Research Article BACKGROUND: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is a tool for diagnostic imaging that has recently spread rapidly in clinical use. At present, the roles played by FDG-PET/CT in determination of margins for surgical resection of sarcoma are unclear. The present study was undertaken to explore the roles of FDG-PET/CT in determination of surgical margins for soft tissue sarcoma and to examine whether PET can serve as a standard means for setting the margins of surgical resection during reduced surgery. METHODS: The study involved 7 patients with sarcoma who underwent surgery in our department and in whom evaluation with FDG-PET/CT was possible. Sarcoma was histologically rated as MFH in 6 cases and leiomyosarcoma in 1 case. In all cases, sarcoma was superficial (T1a or T2a). The tumor border was defined by contrast-enhanced MRI, and SUVs were measured at intervals of 1 cm over a 5-cm long area from the tumor border. Mapping of viable tumor cells was carried out on whole-mount sections of resected tissue, and SUVs were compared with histopathological findings. RESULTS: Preoperative maximum SUVs (SUV-max) of the tumor averaged 11.7 (range: 3.8-22.1). Mean SUV-max was 2.2 (range: 0.3-3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2 cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at 4 cm, and 0.64 (0.45-0.82) at 5 cm. When resected tissue was mapped, tumor cells were absent in the areas where SUV-max was below 1.0. CONCLUSIONS: Our findings suggest that a safe surgical margin free of viable tumor cells can be ensured if the SUV cut-off level is set at 1.0. FDG-PET/CT is promising as a diagnostic imaging technique for setting of safe minimal margins for surgical resection of soft tissue sarcoma. BioMed Central 2011-07-21 /pmc/articles/PMC3224246/ /pubmed/21774838 http://dx.doi.org/10.1186/1471-2474-12-166 Text en Copyright ©2011 Yokouchi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yokouchi, Masahiro Terahara, Mikio Nagano, Satoshi Arishima, Yoshiya Zemmyo, Michihisa Yoshioka, Takako Tanimoto, Akihide Komiya, Setsuro Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma |
title | Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma |
title_full | Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma |
title_fullStr | Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma |
title_full_unstemmed | Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma |
title_short | Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma |
title_sort | clinical implications of determination of safe surgical margins by using a combination of ct and 18fdg-positron emission tomography in soft tissue sarcoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224246/ https://www.ncbi.nlm.nih.gov/pubmed/21774838 http://dx.doi.org/10.1186/1471-2474-12-166 |
work_keys_str_mv | AT yokouchimasahiro clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT teraharamikio clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT naganosatoshi clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT arishimayoshiya clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT zemmyomichihisa clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT yoshiokatakako clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT tanimotoakihide clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma AT komiyasetsuro clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma |